Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02244489
Title Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

pancreatic adenocarcinoma

Therapies

Capecitabine

Oxaliplatin

Momelotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.